28-Nov-2002 - Sigma-Aldrich Chemie GmbH

Sigma-Aldrich Sells Majority of Diagnostics' Chemistry Product Line

Sigma-Aldrich announced that it has sold its key special chemistry and cardiac ("Chemistry") products to Trinity Biotech plc. Terms of the sale were not disclosed.

The Chemistry products represented less than 20% of the discontinued Diagnostics unit's sales and approximately 1.0% of total sales for Sigma-Aldrich in 2001. These products made a modest contribution to overall Sigma-Aldrich profitability. This sale brings the total of Diagnostics products still available to customers through alternate sources to approximately 70% of the discontinued Diagnostic unit's 2001 sales.

In connection with its discontinuance of the Diagnostics business unit, announced in April 2002, the Company recorded a one-time charge of $63 million (net of taxes) in the second quarter of 2002 and indicated that it expected the discontinuance to provide cash of at least $20 million. Purchase prices and transfers of the commitments and employees in connection with the sale of various product lines to date, including this sale to Trinity Biotech plc, have now reduced this one-time charge and increased the expected cash provided by approximately $8 million (net of taxes) and $10 million (net of taxes), respectively. The Company continues to believe that operating what remains of the discontinued Diagnostics business unit as those assets are held for sale should reduce otherwise reportable diluted earnings per share by as much as $.01 in the fourth quarter. Management does not believe that this announced sale of the Chemistry products to Trinity should affect the price of Sigma-Aldrich stock and continues to expect that all Diagnostics activity will be completed by the end of Q1 2003.

Facts, background information, dossiers
  • Trinity Biotech
More about Sigma-Aldrich
  • News

    Sigma-Aldrich strengthens position in RNAi and cell-based assays

    Sigma-Aldrich announced that it has signed a series of agreements that expands its position in the areas of RNA Interference (RNAi), gene expression and cell based assays. Sigma-Aldrich and Genospectra, developer of products to support systems biology and drug discovery efforts, have signed ... more

    2005/2006 Aldrich Handbook Aims to "Advance Science" in Research

    Sigma-Aldrich will release its Aldrich brand's latest handbook of fine chemicals and laboratory equipment. With a new easy-to-read two column format, over 34,000 total products, including 2,500 new listings, more than 20,000 chemical structures/linear formulas, updated application notes and ... more

  • Companies

    Sigma-Aldrich Chemie GmbH

    We are Merck, a global science and technology company determined to solve the toughest problems in life science. Our tools, services, and digital platforms empower scientists and engineers at every stage, helping to deliver scientific breakthroughs. We offer cutting-edge technologies, high ... more

    Sigma-Aldrich Química, S.A. de C.V.

    Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more

    Sigma-Aldrich Chemie GmbH

    more

More about Sigma-Aldrich
  • News

    Merck Completes Sigma-Aldrich Acquisition

    Merck announced the completion of its $ 17 billion acquisition of Sigma-Aldrich, creating one of the leaders in the $ 130 billion global industry. The completion follows last week’s approval from the European Commission, which was the final antitrust condition required to close the Sigma-Al ... more

    Merck Set to Complete Sigma-Aldrich Acquisition

    Merck announced that following the final approval of the European Commission it is set to complete its $17 billion (€13.1 billion) acquisition of Sigma-Aldrich. The European Commission had granted conditional approval to the acquisition of Sigma-Aldrich on June 15, 2015, subject to the dive ... more

    Merck announces Sigma-Aldrich business sale to Honeywell

    Merck announced that Sigma-Aldrich, the U.S. life science company it plans to acquire, agreed to sell parts of its solvents and inorganics business in Europe to Honeywell in fulfilment of commitments made to the European Union in order to win antitrust approval for its $17 billion acquisiti ... more

  • Companies

    Sigma-Aldrich Chemie GmbH

    more

    Sigma-Aldrich Corp.

    Sigma-Aldrich is a leading Life Science and High Technology company. Its biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more

    Sigma-Aldrich Química, S.A. de C.V.

    Sigma-Aldrich is a leading Life Science and High Technology company. Our biochemical and organic chemical products and kits are used in scientific and genomic research, biotechnology, pharmaceutical development, the diagnosis of disease and as key components in pharmaceutical and other high ... more